Exchange: NASDAQ·Updated 04:49 AM EDT
LFMD logo

LFMDLifeMD Inc

$4.14
$0.05
(1.22%)
Pre-Market
Prev Close $4.09
EarningsAug 5
Mkt Cap$208.93M
Vol15.00
News
all
press releases
LifeMD's Series A Preferred Stock Crosses Above 9.5% Yield Territory
In trading on Monday, shares of LifeMD Inc's 8.875% Series A Cumulative Perpetual Preferred Stock (Symbol: LFMDP) were yielding above the 9.5% mark based on its quarterly dividend (annualized to $2.2188), with shares changing hands as low as $22.91 on the day. As of last clos...
Nasdaq News: Markets
More News
CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last?
CareDx (CDNA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
Hims & Hers Expands Integrated Health Access via Platform Expansion
HIMS expands its integrated telehealth ecosystem with a new weight-loss membership and a planned Eucalyptus acquisition to broaden virtual care.
Zacks
Is CAH Becoming the Backbone of US Healthcare Infrastructure?
Cardinal Health is expanding beyond drug distribution into specialty care, logistics and nuclear medicine, deepening its role in US healthcare infrastructure.
Zacks
Bloomberg Businessweek Daily 5/18/2026
Today, Matt Schettenhelm, Bloomberg Intelligence Senior Litigation Analyst, breaks down a California's jury's rejection of Elon Musk's claim that Sam Altman betrayed OpenAI's original mission when it...
Bloomberg Markets and Finance-YouTube
LifeMD (NASDAQ:LFMD) Posts Quarterly Earnings Results, Misses Estimates By $0.06 EPS
LifeMD (NASDAQ:LFMD - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.20) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.06). LifeMD had a negative return on equity of 83.93% and a net margin of 6.58%.The business had...
MarketBeat
LifeMD, Inc. (LFMD) Reports Q1 Loss, Tops Revenue Estimates
LifeMD (LFMD) delivered earnings and revenue surprises of -42.86% and +3.97%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
LifeMD, Inc. (NASDAQ:LFMD) Receives Average Recommendation of "Moderate Buy" from Analysts
LifeMD, Inc. (NASDAQ:LFMD - Get Free Report) has been given an average rating of 'Moderate Buy' by the nine brokerages that are covering the firm, MarketBeat reports. One analyst has rated the stock...
MarketBeat
Hims & Hers Expands DTC Platform to Broaden Access to Personal Care
HIMS broadens its DTC platform with GLP-1 access, a new Benefits hub and global expansion to broaden convenient, personalized care.
Zacks
LifeMD's (LFMD) Buy Rating Reiterated at BTIG Research
BTIG Research restated a "buy" rating and issued a $10.00 price objective on shares of LifeMD in a report on Monday...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.